Showing 1041-1050 of 3319 results for "".
The Colemans: Dermatology as a Father-Son(s) Tradition
https://practicaldermatology.com/topics/feature/colemans-dermatology-father-sons-tradition/26956/The Colemans: Dermatology as a Father-Son(s) TraditionA Tale of Two Toxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-tale-of-two-toxins/22074/From a recent approval to a late-stage candidate, the field is evolving. Experts weigh in on the latest.Focusing on Patient Education in Atopic Dermatitis
https://practicaldermatology.com/topics/practice-management/focusing-on-patient-education-in-atopic-dermatitis/20661/Patients of all ages have atopic dermatitis, and they seek education and support from their dermatologists.DermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesDermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.DermwireTV — Nestle acquires Galderma; Dermatologic procedures surge
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-nestle-acquires-galderma-dermatologic-procedures-surge/19157/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine: Nestle acquires Galderma, dermatologic procedures surge, and we look ahead to the annual meeting in Denver. #DermWireDermwireTV — A big name is getting bigger; ICD-10 looms
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-a-big-name-is-getting-bigger-icd-10-looms/19163/In this premiere edition of DermWireTV, from the publishers of Practical Dermatology® magazine, we take a look at the latest acquisition by Valeant Pharmaceuticals, Inc., explore new data for Galderma's Mirvaso for rosacea, and get insights on the ICD-10 code set transition. #DermWireDeveloping Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and Conditions
https://practicaldermatology.com/topics/feature/developing-core-outcome-sets-importance-common-standards-clinical-studies-specific-diseases-and-conditions/26654/Developing Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and ConditionsYour Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20729/